FDA panel split over safety of Endo's long-acting testosterone injection

Posted on April 19th, 2013 by Logan Lafferty

Federal health experts issued a split opinion Thursday on whether a long-acting testosterone injection from Endo Health Solutions is safe…Panelists who voted against the drug said the risks were not outweighed by the benefits of its long-lasting formulation. "I felt the safety was not quite there yet — admitting that we need a long-term preparation," said Dr. Bart Clarke, of the Mayo Clinic in Rochester, Minn.

 

Star Tribune (AP) by Matthew Perrone

Tags: Dr. Bart Clarke, Endo Health Solutions, Industry News & Competitive Intelligence, Mayo Clinic Rochester, Star Tribune, testosterone, testosterone injection

You must be logged-in to the site to post a comment.

Contact Us · Privacy Policy